Evidence map›Paper›PMID 24684357›Full record

ArticleAmerican journal of respiratory and critical care medicine2014

Tertiary lymphoid structures target the antitumor immune response to lung cancer.

Troy D Randall, Jeffrey A Kern

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Therapeutic Vaccination in Lung Cancer: Past Attempts, Current Approaches and Future Promises.Journal of respiratory biology and translational medicine · 2025
    Article
  2. Review
  3. Article
  4. PD-1Journal for immunotherapy of cancer · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Troy D Randall1 Department of Medicine University of Alabama at Birmingham Birmingham, Alabama.
Jeffrey A Kern

Funding

Unique Aspects of Respiratory ImmunityR01HL069409 · NHLBI · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2001 to 2015
$5.3M
Central and Effector B cells in the LungR01AI097357 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2012 to 2016
$1.8M
Pulmonary Immunity To Pathogens In NeonatesR01AI100127 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2012 to 2016
$1.5M
Role of CCR1 in Cytokine Storm & Immunopathology after influenza infectionR21AI097876 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2012 to 2013
$403k
NHLBI NIH HHS HL069409NHLBI NIH HHS R01 HL069409NIAID NIH HHS AI097357NIAID NIH HHS AI097876NIAID NIH HHS AI100127NIAID NIH HHS R01 AI097357NIAID NIH HHS R01 AI100127NIAID NIH HHS R21 AI097876
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, HumoralB-Lymphocyte SubsetsCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMale

Identifiers

PMID24684357
PMCPMC4225836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.